CanSino Biologics Inc. (HKG: 6185)
Hong Kong
· Delayed Price · Currency is HKD 26.00
-0.10 (-0.38%)
Oct 10, 2024, 4:08 PM HKT
CanSino Biologics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Operating Revenue | 609.52 | 345.18 | 1,031 | 4,300 | 18.54 | - | Upgrade
|
| Other Revenue | 25.09 | 11.9 | 3.55 | - | 6.35 | 2.28 | Upgrade
|
| Revenue | 634.61 | 357.08 | 1,035 | 4,300 | 24.89 | 2.28 | Upgrade
|
| Revenue Growth (YoY) | 47.34% | -65.49% | -75.94% | 17174.82% | 990.05% | -73.62% | Upgrade
|
| Cost of Revenue | 486.2 | 800.83 | 1,218 | 1,298 | 14.73 | 0.39 | Upgrade
|
| Gross Profit | 148.41 | -443.75 | -183.71 | 3,002 | 10.16 | 1.9 | Upgrade
|
| Selling, General & Admin | 571.36 | 639.88 | 535.48 | 327.14 | 95.43 | 65.12 | Upgrade
|
| Research & Development | 485.52 | 637.99 | 778.26 | 878.72 | 428.49 | 151.75 | Upgrade
|
| Other Operating Expenses | 26.31 | -14.16 | -7.24 | 10.18 | 3.91 | 2.95 | Upgrade
|
| Operating Expenses | 1,085 | 1,279 | 1,315 | 1,218 | 527.83 | 219.82 | Upgrade
|
| Operating Income | -936.84 | -1,723 | -1,499 | 1,784 | -517.67 | -217.92 | Upgrade
|
| Interest Expense | -67.59 | -64.15 | -41.34 | -20.42 | - | - | Upgrade
|
| Interest & Investment Income | 115.79 | 173.26 | 161.89 | 125.42 | 63.76 | 25.23 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.94 | 20.58 | 160.64 | -33.78 | -27.36 | 21.72 | Upgrade
|
| Other Non Operating Income (Expenses) | -17.23 | -106.07 | -0.49 | -0.28 | -0.14 | -0.09 | Upgrade
|
| EBT Excluding Unusual Items | -906.81 | -1,699 | -1,218 | 1,855 | -481.41 | -171.06 | Upgrade
|
| Gain (Loss) on Sale of Investments | -92.91 | -14.56 | -4.06 | 71.09 | 6.64 | 0.53 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.14 | 0.18 | - | - | - | - | Upgrade
|
| Asset Writedown | -37.62 | -363.03 | -0.25 | -0.25 | -0.14 | -0.02 | Upgrade
|
| Other Unusual Items | 111.84 | 96.79 | 38.59 | 10.93 | 78.27 | 13.77 | Upgrade
|
| Pretax Income | -925.36 | -1,979 | -1,184 | 1,937 | -396.64 | -156.78 | Upgrade
|
| Income Tax Expense | -9.94 | -12.07 | -219.24 | 29.7 | - | - | Upgrade
|
| Earnings From Continuing Operations | -915.42 | -1,967 | -964.76 | 1,907 | -396.64 | -156.78 | Upgrade
|
| Minority Interest in Earnings | 48.75 | 484.7 | 55.33 | 7.3 | - | - | Upgrade
|
| Net Income | -866.68 | -1,483 | -909.43 | 1,914 | -396.64 | -156.78 | Upgrade
|
| Net Income to Common | -866.68 | -1,483 | -909.43 | 1,914 | -396.64 | -156.78 | Upgrade
|
| Shares Outstanding (Basic) | 247 | 247 | 247 | 247 | 231 | 206 | Upgrade
|
| Shares Outstanding (Diluted) | 247 | 247 | 247 | 247 | 231 | 206 | Upgrade
|
| Shares Change (YoY) | -0.38% | -0.17% | -0.08% | 7.26% | 11.79% | 34.83% | Upgrade
|
| EPS (Basic) | -3.51 | -6.01 | -3.68 | 7.74 | -1.72 | -0.76 | Upgrade
|
| EPS (Diluted) | -3.51 | -6.01 | -3.68 | 7.74 | -1.72 | -0.76 | Upgrade
|
| Free Cash Flow | -939.95 | -1,519 | -2,927 | 846.86 | -638.23 | -271.17 | Upgrade
|
| Free Cash Flow Per Share | -3.80 | -6.16 | -11.84 | 3.42 | -2.77 | -1.31 | Upgrade
|
| Dividend Per Share | - | - | - | 0.800 | - | - | Upgrade
|
| Gross Margin | 23.39% | -124.27% | -17.76% | 69.82% | 40.82% | 83.00% | Upgrade
|
| Operating Margin | -147.63% | -482.38% | -144.89% | 41.49% | -2079.82% | -9543.89% | Upgrade
|
| Profit Margin | -136.57% | -415.23% | -87.90% | 44.52% | -1593.56% | -6866.17% | Upgrade
|
| Free Cash Flow Margin | -148.12% | -425.31% | -282.87% | 19.70% | -2564.19% | -11875.88% | Upgrade
|
| EBITDA | -730.36 | -1,482 | -1,319 | 1,849 | -498.75 | -204.9 | Upgrade
|
| EBITDA Margin | -115.09% | - | -127.47% | 43.01% | - | - | Upgrade
|
| D&A For EBITDA | 206.48 | 240.39 | 180.13 | 65.11 | 18.91 | 13.03 | Upgrade
|
| EBIT | -936.84 | -1,723 | -1,499 | 1,784 | -517.67 | -217.92 | Upgrade
|
| EBIT Margin | -147.63% | - | -144.89% | 41.49% | - | - | Upgrade
|
| Effective Tax Rate | - | - | - | 1.53% | - | - | Upgrade
|
| Revenue as Reported | 634.61 | 357.08 | 1,035 | 4,300 | 24.89 | 2.28 | Upgrade
|
| Advertising Expenses | - | - | - | 9.03 | 0.3 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.